| Literature DB >> 28972165 |
Yoshihiro Hasegawa1,2, Motoko Takahashi3, Shigeru Ariki3, Atsushi Saito3,2, Yasuaki Uehara3,2, Rina Takamiya3, Koji Kuronuma2, Hirofumi Chiba2, Yuji Sakuma4, Hiroki Takahashi2, Yoshio Kuroki3.
Abstract
We recently reported that the lectin surfactant protein D (SP-D) suppresses epidermal growth factor receptor (EGFR) signaling by interfering with ligand binding to EGFR through an interaction between the carbohydrate-recognition domain (CRD) of SP-D and N-glycans of EGFR. Here, we report that surfactant protein A (SP-A) also suppresses EGF signaling in A549 human lung adenocarcinoma cells and in CHOK1 cells stably expressing human EGFR and that SP-A inhibits the proliferation and motility of the A549 cells. Results with 125I-EGF indicated that SP-A interferes with EGF binding to EGFR, and a ligand blot analysis suggested that SP-A binds EGFR in A549 cells. We also found that SP-A directly binds the recombinant extracellular domain of EGFR (soluble EGFR or sEGFR), and this binding, unlike that of SP-D, was not blocked by EDTA, excess mannose, or peptide:N-glycosidase F treatment. We prepared a collagenase-resistant fragment (CRF) of SP-A, consisting of CRD plus the neck domain of SP-A, and observed that CRF directly binds sEGFR but does not suppress EGF-induced phosphorylation of EGFR in or proliferation of A549 cells. These results indicated that SP-A binds EGFR and down-regulates EGF signaling by inhibiting ligand binding to EGFR as well as SP-D. However, unlike for SP-D, SP-A lectin activity and EGFR N-glycans were not involved in the interaction between SP-A and EGFR. Furthermore, our results suggested that oligomerization of SP-A is necessary to suppress the effects of SP-A on EGF signaling.Entities:
Keywords: collectin; epidermal growth factor receptor (EGFR); lung cancer; oligomerization; pulmonary surfactant
Mesh:
Substances:
Year: 2017 PMID: 28972165 PMCID: PMC5682966 DOI: 10.1074/jbc.M117.800771
Source DB: PubMed Journal: J Biol Chem ISSN: 0021-9258 Impact factor: 5.157